Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.

This is an early safety study for a new long-acting injection of the medication brexpiprazole, intended for schizophrenia. It will test single doses in 56 healthy volunteers and people with stable schizophrenia to check for side effects and see how the drug moves through the body…